Evidence map›Paper›PMID 41613046›Full record

ArticleFrontiers in public health2025

A decadal profile of RhD-negative blood donors in Chongqing, China: demographics, phenotypic diversity, and donation behavior.

Yubi Gan, Chengbing Xie, Bujin Liu, Hongren Chen, Weifei Qin

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yubi Gan *Chongqing Blood Center, Chongqing, China.
Chengbing Xie *Chongqing Blood Center, Chongqing, China.
Bujin LiuChongqing Blood Center, Chongqing, China.
Hongren ChenChongqing Blood Center, Chongqing, China.
Weifei QinChongqing Blood Center, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: RhD-negative blood is a critical resource in transfusion medicine due to its rarity and clinical significance. This study provides the first comprehensive analysis of RhD-negative blood donors in Chongqing, China over a decade (2015-2024) to optimize scientific research evidence for optimizing strategies to recruit and retain RhD-negative whole blood donors. Methods: A retrospective cohort of 4,185 RhD-negative donors who donated whole blood to the Chongqing Blood Center from 2015 to 2024 was analyzed. Variables included age, gender, occupation, education level, Rh phenotypes, ABO blood groups, and donation frequency were collected and analyzed to identify factors influencing whole blood donation. Results: In this study, the RhD-negative whole blood donors mainly consisted of donors who had donated only once, with an overall male-to-female ratio of 1.01:1. One-time donors were predominantly students (33.2%) and young adults (49.2% aged 18-25). Active donors correlated with higher education (university degree: 38.6%). The ABO blood group distribution was O > A > B > AB and dominant Rh phenotype was ccdee (50.7%), with rare variants (e.g., CCdEE) absent. Conclusion: This study highlights the need for tailored donor retention strategies and dynamic inventory management for rare subtypes. The findings outline a roadmap for blood centers to address RhD-negative blood shortages and enhance transfusion safety.

Indexed as

Blood DonationBlood DonorsRh-Hr Blood-Group SystemAdolescentAdultChinaFemaleHumansMaleMiddle AgedPhenotypeRetrospective StudiesYoung AdultRh-Hr Blood-Group SystemRho(D) antigendonation behaviorphenotypic diversitypublic health policyRhD-negative blood donation recruitmentRhD-negative whole blood donors

Identifiers

PMID41613046
PMCPMC12847401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.